Mechanisms of ischemic preconditioning and clinical implications for multiorgan ischemic-reperfusion injury

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 1, 1999, Pages 78-91

  Lee, H Thomas ^a,b  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b Milstein Hospital   (United States)

Author keywords

Adenosine; Ischemic preconditioning; Ischemic reperfusion injury; Protein kinase C, K + ATP channel

Indexed keywords

2 CHLOROADENOSINE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; CREATININE; INHALATION ANESTHETIC AGENT; SULFONYLUREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; ISCHEMIA; KIDNEY ISCHEMIA; LUNG TRANSPLANTATION; MULTIPLE ORGAN FAILURE; MYOCARDIAL HIBERNATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; REVIEW; STUNNED HEART MUSCLE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0032972831     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90180-5     Document Type: Review

References (133)

1. Haimovici H: Arterial embolism, myoglobinuria, and renal tubular necrosis. Arch Surg 100:639-645, 1970
2. Kerrigan CL, Stotland MA: Ischemic reperfusion injury: A review. Microsurgery 14:165-175, 1993
3. Menger MD, Pelikan S, Steiner D, Messmer K: Microvascular ischemia-reperfusion injury in striated muscle: Significance of "reflow paradox." Am J Physiol 263:H1901-H1906, 1992
4. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia. A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986
5. Downey JM, Liu GS, Thornton JD: Adenosine and the anti-infarct of preconditioning. Cardiovasc Res 27:3-8, 1993
6. Murry CE, Jennings RB, Reimer KA: New insights into potential mechanisms of ischemic preconditioning. Circulation 84:442-445, 1991
7. Lawson CS, Downey JM: Preconditioning. State-of-the-art myocardial protection. Cardiovasc Res 27:542-550, 1993
8. Lee HT, LaFaro RJ, Reed GE: Pretreatment of human myocardium with adenosine during open-heart surgery. J Card Surg 10:665-676, 1995
9. Uconomidis JS, Weisel RD, Mickle DAG: Ischemic preconditioning: Cardioprotection for cardiac surgery. J Card Surg 9:526-531, 1994 (suppl)
10. Alkhulaifi AM, Yellon DM, Pugsley WB: Preconditioning the human myocardium during aorto-coronary bypass surgery. Eur J Cardiothorac Surg 8:270-276, 1994
11. Yellon DM, Alkhulaifi AM, Pugsley WB: Preconditioning of the human myocardium. Lancet 343:276-277, 1993
12. Lee HT, Lineaweaver WC: Protection against ischemicreperfusion injury of skeletal muscle - Role of ischemic preconditioning and adenosine pretreatment. J Reconst Microsurg 12:383-388, 1996
13. Pang CY, Yang RZ, Zhong A, et al: Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 29:782-788, 1995
14. Mounsey RA, Pang CY, Forrest C: Preconditioning: A new technique for improved muscle flap survival. Otolaryngol Head Neck Surg 107:549-552, 1992
15. Pang CY, Forrest CR: Acute pharmacological preconditioning as a new concept and alternative approach for prevention of skeletal muscle ischemic necrosis. Biochem Pharmacol 49:1024-1034, 1995
16. Pang CY, Forrest CR, Mounsey R: Pharmacological intervention in ischemia-induced reperfusion injury in the skeletal muscle. Microsurgery 14:176-182, 1993
17. Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, et al: Preconditioning: Effect upon modulation in warm liver ischemia. Transplant Proc 25:3303-3304, 1993
18. Egan JC, Knolmayer TJ, Bowyer MW, et al: Systemic pretreatment with adenosine preserves rabbit renal function after ischemia and reperfusion. East Bay Surgical Society Assembly, Monterey, CA, May 7, 1997
19. Turman MA, Bates CM: Susceptibility of human proximal tubular cells to hypoxia: Effect of hypoxic preconditioning and comparison to glomerular cells. Ren Fail 19:47-60, 1997
20. Gidday JM, Fitzgibbons JC, Shah AR, Park TS: Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 168:221-224, 1994
21. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M: Essential role of adenosine, adenosine Al receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A 92:4666-4670, 1995
22. Matsuyama K, Chiba Y, Ihaya A, et al: Effects of spinal cord preconditioning on paraplegia during cross-clamping of the thoracic aorta. Ann Thorac Surg 63:1315-1320, 1997
23. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s; Systemic inflammatory response and organ dysfunction. JAMA 271:226-233, 1994
24. McMillen MA, Huribal M, Sumpio B: Common pathway of endothelial-leukocyte interaction in shock, ischemia, and reperfusion. Am J Surg 166:557-562, 1993
25. Cremer J, Martin M, Redl H, et al: Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61:1714-1720, 1996
26. Henninger DD, Slocum MM, Granger DN: Physiology of reperfusion injury, in White RA, Holder LH (eds): Vascular Surgery: Basic Science and Clinical Correlations. Philadelphia, PA, Lippincott, 1994, pp 337-342
27. Garden DL, Korthuis RJ: Mechanisms of postischemic vascular dysfunction in skeletal muscle: Implication for therapeutic intervention. Microcirc Endothelium Lymphatics 5:277-298, 1989
28. Smith JK, Grisham MB, Granger DN, Korthius RJ: Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol 256:H789-H793, 1989
29. Yokota J, Minei JP, Fantini GA, Shires GT: Role of leukocytes in reperfusion injury of skeletal muscle after partial ischemia. Am J Physiol 257:H1068-H1075, 1989
30. Messent M, Griffiths MJ, Quinlan GJ, et al: Ischemia-reperfusion injury in the rat is modulated by Superoxide generation and leads to an augmentation of the hypoxic pulmonary vascular response. Clin Sci 90:47-54, 1996
31. Korthuis RJ, Grisham MB, Granger DN: Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol 254:H823-H827, 1988
32. Mitchell MB, Winter CB, Banerjee A, Harken AH: The relationship between ischemia-reperfusion injury, myocardial stunning and cardiac conditioning. Surg Gynecol Obstet 177:97-114, 1993
33. Bolli R: Mechanism of myocardial stunning. Circulation 82:723-738, 1990
34. Lo HM, Kloner RA, Braunwald E: Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatment. Am J Cardiol 56:672-677, 1985
35. Shen AC, Jenning RB: Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 67:417-440, 1972
36. Porterfield JK, Kusuoka H, Weisman HF, et al: Ryanodine prevents the changes in myocardial function and morphology induced by reperfusion after brief periods of ischemia. Circ Res 35:315A, 1987
37. Lee HT, Schroeder CA, Shah P, et al: Preconditioning with ischemia or adenosine protects skeletal muscle from ischemic tissue reperfusion injury. J Surg Res 63:29-34, 1996
38. Marts BC, Baudendistel LJ, Naunheim KS, Dahms TE: Protective effect of 2-chloroadenosine on lung ischemic-reperfusion injury. J Surg Res 54:523-529, 1993
39. Hsu K, Wang D, Wu SY, et al: Ischemia-reperfusion lung injury attenuated by ATP-MgC12 in rats. J Appl Physiol 76:545-552, 1994
40. Hotter G, Closa D, Prados M, et al: Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 222:27-32, 1996
41. Tsuruma T, Yagihashi A, Matsuno T, et al: Induction of warm ischemic tolerance following preconditioning of small intestine. Transplant Proc 28:1298-1299, 1996
42. Armstrong S, Downey JM, Ganote CE: Preconditioning of isolated rabbit cardiomyocytes: Induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 28:72-77, 1994
43. Hori M, Kitakaze M, Takashima S, et al: Beneficial role of adenosine in myocardial ischemic and reperfusion injury. Drug Dev Res 28:432-437, 1993
44. Ely SW, Berne RM: Protective effects of adenosine in myocardial ischemia. Circulation 85:893-904, 1992
45. 1 adenosine receptors in rabbit heart. Circulation 84:350-356, 1991
46. Toombs CF, McGee S, Johnston WE, et al: Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86:659-665, 1992
47. Belardinelli L, Linden J, Berne RM: The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73-97, 1989
48. Stiles GL: Adenosine receptors. J Biol Chem 267:6451-6454, 1992
49. Auchampach JA, Gross GJ: Adenosine Al receptors, KATP channels, and ischemia preconditioning in dogs. Am J Physiol 264: H1327-H1336, 1993
50. Ramkumar V, Stiles GL, Beaven MA, Ali H: The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890, 1993
51. Jerome SN, Akimitsu T, Gute DC, Korthuis RJ: Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol 268:H2063-H2067, 1995
52. Miura T, Ogawa T, Iwamoto T, et al: Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation 86:979-985, 1992
53. Urabe K, Miura T, Iwamoto T, et al: Preconditioning enhances myocardial resistance to postischemic myocardial stunning via adenosine receptor activation. Cardiovasc Res 27:657-662, 1993
54. Thornton JD. Liu GS, Olsson RA, Downey JM: Intravenous pretreatment with Al-selective adenosine analogues protects the heart against infarction. Circ Res 85:659-665, 1992
55. Turman MA, Kahn DA, Rosenfeld SL, et al: Characterization of human proximal tubular cells after hypoxic preconditioning: Constitu-live and hypoxia-induced expression of heat shock proteins HSP70 (A, B, and C), HSC 70, and HSP90. Biochem Molec Med 60:49-58, 1997
56. Steenbergen C, Perlman ME, London RE, Murphy E: Mechanism of preconditioning - Ioninc alterations. Circ Res 72:112-125, 1993
57. Hori M, Kitakaze M: Adenosine, the heart and coronary circulation. Hypertension 18:565-574, 1991
58. Nolle D, Lehr A, Messmer K: Adenosine inhibits postischemic leukocyte-endothelium interaction in postcapillary venules of the hamster. Am J Physiol 261 :H651-H655, 1991
59. Cronstein BN: Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13, 1994
60. Keller MW, Geddes L, Spotnitz W, et al: Microcirculatory dysfunction following perfusion with hyperkalemic, hypothermie, cardioplegic solutions and blood reperfusion. Effect of adenosine. Circulation 84:2485-2494, 1991
61. Garrett JG, Auchampach JA: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223-233, 1992
62. Van Winkle DM, Chien GL, Wolff RA, et al: Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol 266:H829-H839, 1994
63. Valen G, Kaszaki J, Nagy S, Vaage J: Open-heart surgery increases the levels of histamine in arterial and coronary sinus blood. Agents Actions 41:11-16, 1994
64. Sandhu R, Thomas U, Diaz RJ, Wilson GJ: Effect of ischemic preconditioning of the myocardium on cAMP. Circ Res 78:137-1147, 1996
65. Hess ML, Kukreja RC: Myocardial stunning. J Card Surg 9:383-386, 1994 (suppl)
66. Kloner RA, Przyklenk K, Hay GL: Clinical evidence for stunned myocardium after coronary artery bypass surgery. J Card Surg 9:397-402, 1994 (suppl)
67. Khuri SF, Farhat T, Zankoul F, et al: Intraoperative assessment of the stunned myocardium versus infarcted myocardium with the simultaneous use of transesophageal echocardiography and the measurement of myocardial pH: Two case studies. J Card Surg 9:403-409, 1994 (suppl)
68. Dawson IT, Hall RJ, Hallman GL, Cooley DA: Mortality in patients undergoing coronary artery bypass surgery after myocardial infarction. Am J Cardiol 33:483-486, 1974
69. Bounous EP, Mark DB, Pollock GB, et al: Surgical survival for coronary disease patients with left ventricular dysfunction. Circulation 78:51-67, 1988 (suppl II)
70. Rich MW, Keller AJ, Schechtman KB, et al: Morbidity and mortality of coronary artery bypass surgery in patients 75 years of age or older. Ann Thorac Surg 46:638-645, 1988
71. Benton GS, Wechsler AS: Coronary revascularization for acute myocardial infarction. Adv Card Surg 3:57-72, 1992
72. Braunwald E, Kloner RA: The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 66:1146-1149, 1982
73. Leesar MA, Stoddard M, Ahmed M, et al: Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 95:2500-2507, 1997
74. Claeys MJ, Vrints CJ, Bosnians JM, et al: Aminophylline inhibits adaptation to ischaemia during angioplasty. Role of adenosine in ischemic preconditioning. Eur Heart J 17:539-544, 1996
75. Bhargava B, Chandra S, Kaul U, et al: Ischemic preconditioning: An intracoronary electrocardiographic study. Indian Heart J 48:129-132, 1996
76. Tomai F, Crea F, Gaspardone A, et al: Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 90:700-705, 1994
77. Okishige K, Yamashita K, Yoshinaga H, et al: Electrophysiologic effects of ischemic preconditioning on QT dispersion during coronary angioplasty. J Am Coll Cardiol 28:70-73, 1996
78. Inoue T, Fujito T, Hoshi K, et al: A mechanism of ischemic preconditioning during percutaneous transluminal coronary angioplasty. Cardiol 87:216-223, 1996
79. Tomai F, Crea F, Gaspardone A, et al: Effects of Al adenosine receptor blockade by bamiphylline on ischemic preconditioning during coronary angioplasty. Eur Heart J 17:846-853, 1996
80. Bums PG, Krukenkamp IB, Caldarone CA, et al: Does cardiopulmonary bypass alone elicit myoprotective preconditioning? Circulation 92:1147-11451, 1995 (suppl II)
81. Vroom M, van Wezel HB: Myocardial stunning, hibernation and ischemic preconditioning. J Cardiothorac Vase Anesth 10:789-799, 1996
82. Kersten JR, Lowe D, Hettrick DA, et al: Glyburide, a KATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 83:27-33, 1996
83. Warltier DC, al-Wathiqui MH, Kampine Schmeling WT: Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 69:552-565, 1988
84. Kanaya N, Kobayashi I, Nakayama M, et al: ATP-sparing effects of isoflurane during ischemia and reperfusion of the canine heart. Br J Anaesth 74:563-568, 1995
85. Drenger B, Ginosar Y, Gozal Y: Effect of halothane on sarcolemmal calcium channels during myocardial ischemia and reperfusion. Adv Pharmacol 31:89-97, 1994
86. White JL, Myers AK, Analouei A, Kim YD: Functional recovery of stunned myocardium is greater with halothane than fentanyl anesthesia. Br J Anaesth 73:214-219, 1994
87. Cope DK, Impastato WK, Cohen MV, Downey JM: Volatile anesthetics protect the rabbit myocardium from infarction. Anesthesiology 86:699-709, 1997
88. Kon S, Imai M, Inaba H: Isoflurane attenuates early neutrophilindependent hypoxia-reoxygenation injuries in the reperfused liver in fasted rats. Anesthesiology 86:128-136, 1997
89. Egan TM, Kaiser LR, Cooper JD: Lung transplantation. Curr Probl Surg 26:680-751, 1989
90. Kuratani T, Matsuda H, Sawa Y, et al: Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass. J Thorac Cardiovasc Surg 103:564-568, 1992
91. Levinson RM, Shure D, Moser KM: Reperfusion pulmonary edema after pulmonary artery thromboarterectomy. Am Rev Resp Dis 134:1241-1245, 1986
92. Kirk AJB, Colquhoun IW, Dark JH: Lung preservation: A review of current practice and future directions. Ann Thorac Surg 56:990-1000, 1993
93. Petsikas D, Rocci MA, Baffour R, et al: Enhanced 24-hour in vitro heart preservation with adenosine and adenosine monophosphate. J Heart Transplant 9:114-118, 1990
94. De Jong JW, Van der Meer P, van Loon H, et al: Adenosine as adjunct to potassium cardioplegia: Effect on function, energy metabolism, and electrophysiology. J Thorac Cardiovasc Surg 100:445-454, 1990
95. Wyatt DA, Ely SW, Lasley RD, et al: Purine-enriched asanguinous cardioplegia retards adenosine triphosphate degradation during ischemia and improves postischemic ventricular function. J Thorac Cardiovasc Surg 97:771-778, 1989
96. Karck M, Rahmanian P, Haverich A: Ischemic preconditioning enhances donor heart preservation. Transplantation 62:17-22, 1996
97. Du ZY, Hicks M, Winlaw D, et al: Ischemic preconditioning enhances donor lung preservation in the rat. J Heart Lung Transplant 15:1258-1267, 1996
98. Crawfold ES, Rubio PA: Reappraisal of adjuncts to avoid ischemia in the treatment of aneurysms of descending thoracic aorta. J Thorac Cardiovasc Surg 66:693-704, 1973
99. Mauney MC, Blackbourne LH, Langenburg SE, et al: Prevention of spinal cord injury after repair of the thoracic or thoracoabdominal aorta. Ann Thorac Surg 59:245-252, 1995
100. Phillis JW, O'Regan MH: Prevention of ischemic brain injury by adenosine receptor activation. Drug Dev Res 28:390-394, 1990
101. Sweeney MI: Neuroprotective effects of adenosine in cerebral ischemia: Window of opportunity. Nuerosci Behav News 21:207-217, 1997
102. Ildan F, Oner A, Isbir T, et al: Correlation of alterations on Na+-K+/Mg2+ ATPase activity, lipid peroxidation and ultrastructural findings following experimental spinal cord injury with and without intravenous methylprednisolone treatment. Neurosurg Rev 18:35-44, 1995
103. Panter SS, Faden AI: Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci Lett 136:165-168, 1992
104. Yanase M, Sakou T, Fukuda T: Role of N-methyl-D-aspartate receptor in acute spinal cord injury. J Neurosurg 83:884-888, 1995
105. Choi DW: Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists. Stroke 21:11120-11122, 1990 (suppl III)
106. Seibel PS, Theodore P, Kron IL, Tribble CG: Regional adenosine attenuates postischemic spinal cord injury. J Vase Surg 18:153-160, 1993
107. Bhardwaj A, Northington FJ, Koehler RC, et al: Adenosine modulates N-methyl-D-aspartate-stimulated hippocampal nitric oxide production in vivo. Stroke 26:1627-1633, 1995
108. Roumen RM, Van der Vliet A, Wevers RA, Goris RJA: Intestinal permeability is increased after major vascular surgery. J Vase Surg 17:734-737, 1993
109. Hardy KJ, McClure DN, Subwongcharoen S: Ischaemic preconditioning of the liver: A preliminary study. Aust N Z J Surg 66:707-710, 1996
110. Isozaki H, Adam R, Gigou M, et al: Experimental study of the protective effects of intermittent hepatic pedicle clamping in the rat. Br J Surg 79:310-313, 1992
111. Kume M, Yamamoto Y, Saad S, et al: Ischemic preconditioning of the liver in rats: Implication of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 128:251-258, 1996
112. Yoshikawa T, Inoue S, Abe S, et al: Acute myocardial infarction: Clinical characteristics and significance of preinfarction angina. Cardiology 82:42-47, 1993
113. Hirai T, Fujita M, Yoshida N, et al: Importance of ischemic preconditioning and collateral circulation for left ventricular function recovery in patients with successful intracoronary thromolysis for acute myocardial infarction. Am Heart J 126:827-831, 1993
114. Alkhulaifi AM: Preconditioning the human heart. Ann R Coll Surg Engl 79:49-54, 1997
115. Jenkins DP, Pugsley WB, Alkhulaifi AM, et al: Ischaemic preconditioning reduces troponin-T release in patients undergoing coronary artery bypass surgery. Heart 77:314-318, 1997
116. Walker DM, Walker JM, Pugsley WB, et al: Preconditioning in isolated superfused human muscle. Mol Cell Cardiol 27:1349-1357, 1995
117. Speechly-Dick ME, Grover GJ, Yellon DM: Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial model in vitro model. Circ Res 77:1030-1035, 1995
118. Jacobson E, Young CJ, Aronson S, et al: The role of ischemic preconditioning during minimally invasive coronary bypass surgery. J Thorac Cardiovasc Anesth 10:787-792, 1997
119. Latham P, Joshi GP: Coronary revascularization without cardiopulmonary bypass: Use of ischemic preconditioning and adenosine. Anesthesiology 88:828-830, 1998
120. Klimt CR, Knatterud GL, Meinert CL, Prout TE (UDGP): A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19:747-830, 1970
121. Engler R, Yellon D: Sulfonylurea KATP channel blockade in type II diabetes and preconditioning in cardiovascular diseases. Circulation 94:2297-2301, 1996
122. Rytter L, Troelsen S, Beck-Lielsen H: Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 8:230-234, 1985
123. Cleveland JC, Meldrum DR, Cain BS, et al: Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium; Two paradoxes revisited. Circulation 96:29-32, 1997
124. Mullane K: Acadesine: The prototype adenosine-regulating agent for reducing myocardial ischaemic injury. Cardiovasc Res 27:43-47, 1993
125. Mullane K, Young M: Acadesine: Prototype adenosine-regulating agent for treating myocardial ischemia-reperfusion injury. Drug Dev Res 28:336-343, 1993
126. Young MA, Mazur C, Mullane K: Acadesine attenuates ischemic cardiac dysfunction in the isolated blood-perfused rabbit heart. Drug Dev Res 31:157-163, 1994
127. Tsuchida A, Yang XM, Burckhartt B, et al: Acadesine extends the window of opportunity afforded by ischemic preonditioning. Cardiovasc Res 28:379-383, 1994
128. Alkhulaifi AM, Pugsley WB: Role of acadesine in clinical myocardial protection. Br Heart J 73:304-305, 1995
129. Boiling SF, Groh MA, Mattson AM, et al: Acadesine (AICAriboside) improves postischemic cardiac recovery. Ann Thorac Surg 54:93-98, 1992
130. Schoenberg MH, Poch B, Marzinzig DM, et al: Effect of acadesine treatment on postischemic damage to small intestine. Am J Physiol 269:H1752-H1759, 1995
131. Leung JM, Stanley T, Mathew J, et al: An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine inpatients undergoing coronary artery bypass graft surgery. Anesth Analg 78:420-434, 1994
132. Menasche P, Jamieson WRE, Flameng W, Davies MK: Acadesine: A new drag that may improve myocardial protection in coronary artery bypass grafting. J Thorac Cardiovasc Surg 110:1096-1106, 1995
133. Mangano TD: Effects of acadesine on myocardial infarction, stroke and death following surgery. A meta-analysis of the 5 international radomized trials. JAMA 277:325-332, 1997